Skip to main content

Guidance 9: Therapeutic goods that contain or are produced from human blood or plasma

(Previously ARGPM Appendix 9: Policy on medicines derived from human blood or plasma)

Guidance on the regulatory requirements for therapeutic goods that contain, or are produced from, human blood or plasma

Last updated

Help us improve the Therapeutic Goods Administration site